Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENDS Influence on Smoking and Demand
NCT04709471Phase 2Completed
- Sponsor
- The University of Vermont
- Start
- Jan 2021
- Primary completion
- Apr 2022
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (3 arms), sponsored by The University of Vermont. Primary endpoints: Feasibility at 4 weeks, Combustible cigarette smoking at 4 weeks and 2 more. Started Jan 2021; status: completed.
Beyond the preview
Go deeper on NCT04709471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04709471.